Literature DB >> 32412705

Compassionate Use of Remdesivir in Covid-19.

Stefanos Bonovas1, Daniele Piovani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32412705     DOI： 10.1056/NEJMc2015312

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

Review 1.  FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy.

Authors:  Sylwester Drożdżal; Jakub Rosik; Kacper Lechowicz; Filip Machaj; Katarzyna Kotfis; Saeid Ghavami; Marek J Łos
Journal:  Drug Resist Updat       Date:  2020-07-15       Impact factor: 18.500

2.  Pirfenidone: A novel hypothetical treatment for COVID-19.

Authors:  Soroush Seifirad
Journal:  Med Hypotheses       Date:  2020-06-17       Impact factor: 1.538

3.  Awake Prone Positioning in COVID-19 Patients.

Authors:  Prabhanjan Singh; Prerana Jain; Himanshu Deewan
Journal:  Indian J Crit Care Med       Date:  2020-10

4.  Study of critically ill patients with COVID-19 in New York City.

Authors:  Daniele Piovani; Stefanos Bonovas
Journal:  Lancet       Date:  2020-10-10       Impact factor: 79.321

5.  Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis.

Authors:  Afra Rezagholizadeh; Sajad Khiali; Parvin Sarbakhsh; Taher Entezari-Maleki
Journal:  Eur J Pharmacol       Date:  2021-02-04       Impact factor: 5.195

6.  Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population.

Authors:  Zhigang Yi; Yun Ling; Xiaonan Zhang; Jieliang Chen; Kongying Hu; Yuyan Wang; Wuhui Song; Tianlei Ying; Rong Zhang; HongZhou Lu; Zhenghong Yuan
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

7.  Joint analysis of duration of ventilation, length of intensive care, and mortality of COVID-19 patients: a multistate approach.

Authors:  Derek Hazard; Klaus Kaier; Maja von Cube; Marlon Grodd; Lars Bugiera; Jerome Lambert; Martin Wolkewitz
Journal:  BMC Med Res Methodol       Date:  2020-08-11       Impact factor: 4.615

Review 8.  Clinical studies assessing the efficacy, effectiveness and safety of remdesivir in management of COVID-19: A scoping review.

Authors:  Juan Pimentel; Cassandra Laurie; Anne Cockcroft; Neil Andersson
Journal:  Br J Clin Pharmacol       Date:  2020-12-15       Impact factor: 3.716
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.